Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
37.77(c) 37.54(c) 37.15(c) 36.86(c) 37.17(c) Last
11 197 193 8 140 363 11 643 964 15 048 324 12 406 749 Volume
-1.74% -0.61% -1.04% -0.78% +0.84% Change
More quotes
Financials (USD)
Sales 2020 10 061 M - -
Net income 2020 429 M - -
Net Debt 2020 7 266 M - -
P/E ratio 2020 125x
Yield 2020 -
Sales 2021 11 945 M - -
Net income 2021 1 571 M - -
Net Debt 2021 5 213 M - -
P/E ratio 2021 33,3x
Yield 2021 -
Capitalization 53 178 M 53 178 M -
EV / Sales 2020 6,01x
EV / Sales 2021 4,89x
Nbr of Employees 36 000
Free-Float 85,0%
More Financials
Company
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.1%): products used in cardiology surgeries (42.9% of net sales), cardiac rhythm management (29.6%), peripheral surgeries (21.2%), and other (6.4%); - endodontic surgery (30.8%): equipment used in endoscopy (57.3% of net... 
More about the company
Notations Surperformance© of Boston Scientific Corporation
Trading Rating : Investor Rating :
More Ratings
All news about BOSTON SCIENTIFIC CORPORATION
10/23BOSTON SCIENTIFIC CORPORATION : quaterly earnings release
10/12BOSTON SCIENTIFIC : Currently Up For Ninth Straight Day, Would Equal June 2005 W..
DJ
10/06BOSTON SCIENTIFIC : SARACA Adds New Senior Vice President for North America Busi..
AQ
10/05BOSTON SCIENTIFIC CORP : Change in Directors or Principal Officers (form 8-K)
AQ
10/01BOSTON SCIENTIFIC : Announces Transcatheter Cardiovascular Therapeutics 2020 Inv..
PR
09/30BOSTON SCIENTIFIC : Launches WaveWriter Alpha™ Spinal Cord Stimulator Syst..
PR
09/28BOSTON SCIENTIFIC : Launches ACURATE neo2™ Aortic Valve System in Europe
PR
09/24BOSTON SCIENTIFIC : Pulmonx Corp. Sets IPO at 6.67 Million Shares; Sees Pricing ..
DJ
09/21BOSTON SCIENTIFIC : Announces Expanded Investment and Exclusive Acquisition Opti..
PR
09/09BOSTON SCIENTIFIC : Launches Vercise Genus™ DBS System In Europe
PR
09/03BOSTON SCIENTIFIC : CMS Grants Additional Reimbursement For The Eluvia™ Dr..
PR
08/26BOSTON SCIENTIFIC : Announces September 2020 Conference Schedule
PR
08/10BOSTON SCIENTIFIC : Guggenheim MedTech Disruptors Virtual Conference Presentatio..
PU
08/05BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
08/03BOSTON SCIENTIFIC CORP : Change in Directors or Principal Officers (form 8-K)
AQ
More news
News in other languages on BOSTON SCIENTIFIC CORPORATION
10/23BOSTON SCIENTIFIC CORPORATION : Veröffentlichung des Quartalsergebnisses
10/23BOSTON SCIENTIFIC CORPORATION : publication des résultats trimestriels
07/28TAGESVORSCHAU : Termine am 29. Juli 2020
07/24BOSTON SCIENTIFIC CORPORATION : Veröffentlichung des Halbjahresergebnisses
07/24BOSTON SCIENTIFIC CORPORATION : publication des résultats semestriels
More news
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 46,31 $
Last Close Price 37,17 $
Spread / Highest target 34,5%
Spread / Average Target 24,6%
Spread / Lowest Target 15,7%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward F. Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy Chief Information Officer & SVP
Sector and Competitors